FacultyFaculty/Author Profile
Leslie Fischer, Ph.D.

Leslie Fischer, Ph.D.

Novartis Pharmaceuticals Corporation
Principal Patent Attorney, I&D, NS, Ophtha Patent Group
East Hanover, NJ, USA


Dr. Leslie Fischer, Ph.D., J.D. is a Principal Patent Attorney at Novartis Pharmaceuticals Corp. in East Hanover, NJ.  She focuses on global patent prosecution, freedom to operate, regulatory exclusivity, licensing, contractual negotiations, and due diligences.  Her technology area of expertise is biopharmaceutical products, particularly for the treatment of autoimmune diseases.  Dr. Fischer is also Novartis Pharmaceutical’s designated liaison to the United States Patent Office (USPTO), a role created to enhance the relationship, facilitate dialogue, and share information between these entities.  She also teaches mechanical patent claim drafting as an adjunct professor of law at Seton Hall Law School, in Newark, NJ. 

Prior to joining Novartis in 2007, Dr. Fischer was an associate attorney at Fitzpatrick, Cella, Harper and Scinto in New York, during which time she provided detailed opinion work for a broad range of clients, consulted on biotechnology litigation, and performed pharmaceutical and biotechnology patent prosecution.

Dr. Fischer holds a J.D. from Rutgers University, and a Ph.D. in Biochemistry from Thomas Jefferson University in Philadelphia. Her Ph.D. thesis focused on the interaction of Bone Morphogenetic Proteins and Wnts during mouse limb development, with her work appearing in Osteoarthritis and Cartilage, the Journal of Cellular Biochemistry, and the Journal of Biological Chemistry.

Dr. Fischer has appeared as a speaker and panelist in numerous public forums.  Most recently, she presented on patent subject matter eligibility at the 12th Annual Advanced Patent Law Institute, which was sponsored by the University of Texas School of Law and the USPTO, March 9-10, 2017, Alexandria, VA.  For the past three years, she has also acted as co-chair of American Conference Institute’s “Advanced Summit on Life Sciences Patents" meeting, which is held yearly in New York, NY.

Leslie Fischer, Ph.D. is associated with the following items:
CHB Chapters  CHB Chapters Section 101 Challenges in Post-Grant Review (June 2017) - USPTO Post-Grant Patent Trials 2017, Monday, September 25, 2017
Obvious-Type Double Patenting: The Creep of Gilead - Intellectual Property Law Institute 2017, Monday, October 02, 2017
Web Segment  Web Segment Northeast Corridor: Bio/Pharma at the PTAB - USPTO Post-Grant Patent Trials 2017, Wednesday, September 27, 2017
The Implications of Intellectual Property Issues for Corporate Counsel - Intellectual Property Law Institute 2017, Wednesday, October 04, 2017
MP3 Audio  MP3 Audio Northeast Corridor: Bio/Pharma at the PTAB - Northeast Corridor: Bio/Pharma at the PTAB, Wednesday, September 27, 2017
The Implications of Intellectual Property Issues for Corporate Counsel - The Implications of Intellectual Property Issues for Corporate Counsel, Wednesday, October 04, 2017
Transcripts  Transcripts Northeast Corridor: Bio/Pharma at the PTAB - Northeast Corridor: Bio/Pharma at the PTAB, Wednesday, September 27, 2017
The Implications of Intellectual Property Issues for Corporate Counsel - The Implications of Intellectual Property Issues for Corporate Counsel, Wednesday, October 04, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Northeast Corridor: Bio/Pharma at the PTAB - Northeast Corridor: Bio/Pharma at the PTAB, Wednesday, September 27, 2017
The Implications of Intellectual Property Issues for Corporate Counsel - The Implications of Intellectual Property Issues for Corporate Counsel, Wednesday, October 04, 2017
On-Demand Web Programs  On-Demand Web Programs USPTO Post-Grant Patent Trials 2017, Wednesday, October 04, 2017, New York, NY
Intellectual Property Law Institute 2017, Sunday, October 08, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.